random-effects – Communicable Diseases Research

Ozone as an adjuvant therapy for COVID-19: A systematic review and meta-analysis

Research article

Published on 2022-09-012022-10-05
Journal: International immunopharmacology [Category] 임상,

Updated Living Systematic Review and Meta-analysis of Controlled Trials of Mesenchymal Stromal Cells to Treat COVID-19: A Framework for Accelerated Synthesis of Trial Evidence for Rapid Approval-FASTER Approval

COVID-19를 치료하기 위한 중간엽 간질 세포의 통제된 시험에 대한 업데이트된 살아있는 체계적인 검토 및 메타 분석: 신속한 승인-빠른 승인을 위한 시험 증거의 가속화된 합성을 위한 프레임워크

Meta-Analysis

Published on 2022-07-202022-09-11
Journal: Stem cells translational medicine [Category] 임상,

[키워드] accelerate accelerated acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 appear approval ARDS Clinical studies clinical study conducted Consistency Control Controlled controls coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 criteria Critical death Endpoint evaluate Evidence Exosomes Extracellular Extracellular vesicles facilitate framework heterogeneity Hospital stay identify IMPROVE ISCT Master protocol mean difference Mesenchymal stem cells Mesenchymal stromal cell Mesenchymal stromal cells Meta-analysis Microvesicles moderate Mortality MSC MSC-EVs exosomes MSCs non-randomized study outcome Oxygenation Patient Pneumonia PROSPERO protocol random-effect random-effects Random-effects meta-analysis Randomized controlled trial Rapid reduce reduce mortality Relative risk reported respiratory distress Respiratory distress syndrome review risk of bia risk of death RoB SARS-CoV-2 Sepsis severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 Society stromal cell stromal cells synthesis systematic review treat Treatment
[DOI] 10.1093/stcltm/szac038 PMC 바로가기 [Article Type] Meta-Analysis

Mesenchymal stem/stromal cell-based therapies for COVID-19: First iteration of a living systematic review and meta-analysis: MSCs and COVID-19

COVID-19에 대한 중간엽 줄기/기질 세포 기반 치료법: 살아있는 체계적인 검토 및 메타 분석의 첫 번째 반복: MSC 및 COVID-19

Meta-Analysis

Published on 2022-06-012022-09-11
Journal: Cytotherapy [Category] COVID19(2023년), SARS, 치료기술,

[키워드] 95% CI 95% confidence interval acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adherence adverse effects Analysis appear case sery Cell Cell-based therapy Clinical outcome Control coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 criteria Critical determine Efficacy Endpoint estimate Exosomes Extracellular Extracellular vesicles Follow-up Future heterogeneity immunomodulatory interleukin-6 ISCT iteration Mesenchymal stem cells Mesenchymal stromal cells Meta-analysis Microvesicles moderate Mortality MSC MSCs nine not performed Other outcome Other outcomes pandemic patients patients with COVID-19 performed Pneumonia potential risk primary analysis random-effect random-effects repeated reported respiratory distress Respiratory distress syndrome risk risk of bia risk of death risk ratio RoB SARS-CoV-2 Secondary outcomes secreted Sepsis severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 standardized mean difference Statistical power stromal cells Study design systematic review therapy for COVID-19 tissue repair treat
[DOI] 10.1016/j.jcyt.2021.12.001 PMC 바로가기 [Article Type] Meta-Analysis

Compliance Indicators of COVID-19 Prevention and Vaccines Hesitancy in Kenya: A Random-Effects Endogenous Probit Model

Article

Published on 2021-11-192022-10-28
Journal: Vaccines [Category] COVID-19,

Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis

실제 연구에서 SARS-CoV-2 백신의 효과 및 안전성: 체계적인 검토 및 메타 분석

Review

Published on 2021-11-142022-09-10
Journal: Infectious Diseases of Poverty [Category] MERS, SARS, 변종,

[키워드] 95% CI 95% confidence interval Admissions adverse event adverse events Alpha Alpha variant Beta Beta variant coronavirus disease Coronavirus disease 2019 Coverage COVID-19 COVID-19 vaccine COVID-19 vaccines COVID-19-related death death delta variant dose effective Effectiveness evaluate examined Final Gamma global pandemic herd immunity Hospitalization ICU ICU admissions immune immune surveillance Immunity inception incidence rate increasingly Infection intensive care unit Meta-analysis Mutation observational studies observational study pandemic Prevent protective effect random-effects Rapid reduce Result resulting Safety SARS-CoV-2 SARS-CoV-2 infections SARS-CoV-2 vaccine SARS-CoV-2 vaccines SARS-CoV-2 variants searched severe adverse events severe cases single dose supplementary material Surveillance symptomatic symptomatic cases symptomatic COVID-19 systematic review vaccination Vaccine variant variants Web of Science were used
[DOI] 10.1186/s40249-021-00915-3 PMC 바로가기 [Article Type] Review

Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol

Covid-19에 대한 치료 중재로서의 중간 엽 기질 세포 : 살아있는 체계적인 검토 및 메타 분석 프로토콜

Protocol

Published on 2021-09-152022-08-31
Journal: Systematic Reviews [Category] COVID-19, meta-analysis, SARS,

[키워드] activated acute respiratory distress syndrome adverse event adverse events ARDS benefit Case series characterization Clinical outcome clinical study Community concerning conditioned media Controlled controlled trials Coronavirus disease 2019 COVID-19 CRD data extraction database determine Efficacy Evidence Exosomes extracellular vesicle Extracellular vesicles global pandemic Health Health policy immune response immune responses immunomodulatory information Isolation Laboratory lack life-threatening Mesenchymal stem cells Mesenchymal stromal cell Mesenchymal stromal cells meta-analyses Meta-analysis Microvesicles Mild MSC MSCs non-randomized outcomes pandemic Patient patient population performed Pneumonia populations protocol random-effect random-effects Random-effects meta-analysis Randomized real time SARS-CoV-2 SARS-COV-2 infection secreted Secretome Sepsis severe acute respiratory syndrome coronavirus 2 stromal cells subsequent supplementary material systematic literature search systematic review therapeutic intervention tissue repair treat trials
[DOI] 10.1186/s13643-021-01803-5 PMC 바로가기 [Article Type] Protocol

The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials

코로나19로 입원한 환자의 사망률에 대한 토실리주맙의 효과: 무작위 대조 시험의 메타 분석

Meta-Analysis

Published on 2021-08-012022-09-11
Journal: European Journal of Clinical Pharmacology [Category] MERS, 임상, 진단, 치료제,

[키워드] 95% CI 95% confidence interval all-cause mortality appear benefit bias clinical clinical benefits clinical trial composite endpoint Controlled controlled trials coronavirus disease Coronavirus disease 2019 COVID-19 database effect size Evidence Google Scholar hazard ratio heterogeneity hospitalized patient hospitalized patients Hypothesis indicated likelihood mechanical ventilation medRxiv Meta-analysis Mortality no significant effect Patient patients with COVID-19 progression random-effect random-effects Randomized controlled trial Randomized controlled trials randomized trials RCT RCTs reduce Repository risk risk of bia Risk of bias Sample size searched significant effect Tocilizumab Trial Version with COVID-19
[DOI] 10.1007/s00228-021-03087-z PMC 바로가기 [Article Type] Meta-Analysis